SIAP
GEN

Sterling Investment Advisors (Pennsylvania)’s Genesis Healthcare, Inc. GEN Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300
Closed – – 579
2022
Q2 		$0 Hold
300
– – ﹤0.01% 658
2022
Q1 		$0 Hold
300
– – ﹤0.01% 641
2021
Q4 		$0 Hold
300
– – ﹤0.01% 637
2021
Q3 		$0 Hold
300
– – ﹤0.01% 623
2021
Q2 		$0 Hold
300
– – ﹤0.01% 594
2021
Q1 		$0 Hold
300
– – ﹤0.01% 552
2020
Q4 		$0 Hold
300
– – ﹤0.01% 490
2020
Q3 		$0 Hold
300
– – ﹤0.01% 477
2020
Q2 		$0 Buy
+300
New +$241 ﹤0.01% 457

Sterling Investment Advisors (Pennsylvania)'s GEN Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Genesis Healthcare, Inc. (GEN) in Q3 2022, closing a stake of 300 shares.

Sterling Investment Advisors (Pennsylvania) first reported a position in GEN in Q2 2020 and held it in 9 quarters. The position peaked at $0 in Q2 2022. 0 funds tracked by Wall St. Rank hold GEN as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Genesis Healthcare, Inc. position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 300 Genesis Healthcare, Inc. shares in Q3 2022.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Genesis Healthcare, Inc. in Q2 2020 and held it in 9 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Genesis Healthcare, Inc. position peaked at $0 in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.